Plasma Expander Market Synopsis:
Plasma Expander Market Size Was Valued at USD 6.97 Billion in 2023, and is Projected to Reach USD 20.44 Billion by 2032, Growing at a CAGR of 12.7 % From 2024-2032.
The Plasma Expander Market spans the manufacturing and use of products intended for replenishing blood plasma volume in patients diagnosed with low blood plasma levels because of trauma, surgery, burns, and other causes. These products are important in the management of a patient’s fluid balance and the avoidance of such possible complications as hypovolemic shock The most commonly used plasma expanders are albumin, dextran, hydroxyethyl starch, and gelatin.
Plasma Expander Market is growing at a steady pace and the market continuously steams due to the rise in trauma cases, surgical procedures and enhanced emergency care. The developments of the global healthcare systems and the increase in numerous road accidents with subsequent burn injuries have driven the market. In the current research, the pool of developed nations is a significant income generator due to better health structures and increased use of superior medical technology. In the same time though, the emerging economies are on the rise because the access to health care as well as awareness about plasma expanders is increasing.
The increasing prevalence of technological advancements in increasing surgical effectiveness and product use in the ICUs is a driver to the market’s expansion. Although the high cost of natural plasma expanders such as albumin and adverse effects related to synthetic substitutes might limit the expansion of this market, further studies and product development shall continue to unlock growth in this market.
Plasma Expander Market Trend Analysis:
Shift Toward Synthetic Plasma Expanders
-
The shift toward synthetic plasma expanders is becoming a significant market driver in the plasma expander industry. As healthcare providers seek alternatives to traditional blood products, synthetic plasma expanders offer a safer and more cost-effective solution. These expanders, typically derived from synthetic materials like hydroxyethyl starch (HES), provide efficient volume replacement without the risks associated with blood transfusions, such as disease transmission or immune reactions. They are especially beneficial in emergency and surgical settings, where rapid fluid replacement is necessary.
- The growing demand for synthetic plasma expanders is fueled by the increasing focus on patient safety, a rise in surgeries, trauma cases, and advancements in medical research. Furthermore, the ability to store and handle synthetic products more easily than blood-based alternatives adds to their appeal, propelling growth in this segment of the market.
Expansion in Emerging Economies
-
The expansion of the plasma expander market in emerging economies presents a significant growth opportunity. As healthcare infrastructure improves in these regions, there is a rising demand for advanced medical solutions, including plasma expanders. The increasing prevalence of trauma, surgeries, and critical care requirements in these regions is driving the need for effective fluid replacement therapies.
- Synthetic plasma expanders, due to their affordability, ease of storage, and reduced risk of complications, are particularly attractive in these markets. Governments and healthcare organizations are also focusing on improving patient care, further boosting the demand for these products. The growing awareness of synthetic alternatives over traditional blood transfusions is contributing to their adoption. This market expansion offers a promising opportunity for companies to penetrate emerging economies and capitalize on the growing healthcare needs.
Plasma Expander Market Segment Analysis:
Plasma Expander Market is Segmented on the basis of Type, Application, End User, and Region.
By Type, Albumin segment is expected to dominate the market during the forecast period
-
The plasma albumin segment is expected to capture the largest share of the Plasma Expander Market during the forecast period since it is a highly effective solution for stabilising plasma oncotic pressure and is used in various intensive care facilities. Sourced from human plasma, albumin is widely utilised in the treatment of burn, liver diseases and acute hypovolemic diseases.
- The fact that it can maintain homeostasis, especially in influencing haemodynamic data and redistributing necessary products, such as hormones and vitamins, makes it popular in hospitals and emergency departments. Still, the expensive price range, and limited availability of albumin may lead to the need for synthetic substitutes in some areas.
By Application, the Trauma and Surgical procedures segment expected to held the largest share
-
The traumatic and surgical operations segment will remain the largest growth area of the market owing to the growing number of accidents, surgeries, andcases of emergencies across the globe. Blood plasma expanders are especially useful in the assessment of patients who undergo surgeries by replacing the plasma component and thus avoiding hypovolemic shock.
- Cost pressures which have led to a focus on enhancing operating room efficiency and an overall increase in elective and non-elective surgeries are the two major drivers of this segment. Also, with the increased use of operating room technologies in medical practice, plasma expanders have been boosted further.
Plasma Expander Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
-
North America Dominates the Market & Such dominance is attributed to its enhanced health care system, high awareness of plasma expander products and growing focus on adding trauma care and surgical solutions. A large number of hospitals and emergency care centers in America make America the region’s market leader in the global market. Also, the increasing trends related to chronic diseases that need volume replacement therapy and having key market players strengthen North America’s position.
- Canada is also expected to have a major influence in the regional rates as a result of overall increase in healthcare spending along with enhancement of trauma and critical care procedures management. In addition, development and fabrication of synthetic plasma expanders in North America continue to achieve significant breakthroughs and a related research effort ensures that North America will maintain its strong market position in the long run.
Active Key Players in the Plasma Expander Market:
- B. Braun Melsungen AG (Germany)
- Baxter International Inc. (United States)
- BioTime, Inc. (United States)
- CSL Limited (Australia)
- Fresenius Kabi AG (Germany)
- Grifols, S.A. (Spain)
- HemaCare Corporation (United States)
- Kedrion S.p.A. (Italy)
- Octapharma AG (Switzerland)
- Pfizer Inc. (United States)
- Sanquin Blood Supply Foundation (Netherlands)
- Shire (now part of Takeda Pharmaceutical Company) (Japan)
- Sichuan Kelun Pharmaceutical Co., Ltd. (China)
- Terumo Corporation (Japan)
- Zhongyuan Union Cell & Gene Engineering Corp. Ltd. (China)
- Other Active Players
|
Global Plasma Expander Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 6.97 Billion |
|
Forecast Period 2024-32 CAGR: |
12.7 % |
Market Size in 2032: |
USD 20.44 Billion |
|
Segments Covered: |
By Type |
|
|
|
By Application |
|
||
|
By End User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Plasma Expander Market by Type
4.1 Plasma Expander Market Snapshot and Growth Engine
4.2 Plasma Expander Market Overview
4.3 Pure PRP Leucocyte-rich PRP Pure Platelet-rich Fibrin (PRF) Leukocyte-rich Fibrin (L-PRF)
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Pure PRP Leucocyte-rich PRP Pure Platelet-rich Fibrin (PRF) Leukocyte-rich Fibrin (L-PRF): Geographic Segmentation Analysis
Chapter 5: Plasma Expander Market by Application
5.1 Plasma Expander Market Snapshot and Growth Engine
5.2 Plasma Expander Market Overview
5.3 Infectious Diseases Dental Nerve Injury Cardiac Muscle Injury Other
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Infectious Diseases Dental Nerve Injury Cardiac Muscle Injury Other: Geographic Segmentation Analysis
Chapter 6: Plasma Expander Market by End User
6.1 Plasma Expander Market Snapshot and Growth Engine
6.2 Plasma Expander Market Overview
6.3 Hospitals and Clinics Research Institutes Others
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospitals and Clinics Research Institutes Others: Geographic Segmentation Analysis
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Benchmarking
7.1.2 Plasma Expander Market Share by Manufacturer (2023)
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Mergers and Acquisitions
7.2 B. BRAUN MELSUNGEN AG (GERMANY)
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Role of the Company in the Market
7.2.5 Sustainability and Social Responsibility
7.2.6 Operating Business Segments
7.2.7 Product Portfolio
7.2.8 Business Performance
7.2.9 Key Strategic Moves and Recent Developments
7.2.10 SWOT Analysis
7.3 BAXTER INTERNATIONAL INC. (UNITED STATES)
7.4 BIOTIME INC. (UNITED STATES)
7.5 CSL LIMITED (AUSTRALIA)
7.6 FRESENIUS KABI AG (GERMANY)
7.7 GRIFOLS
7.8 S.A. (SPAIN)
7.9 HEMACARE CORPORATION (UNITED STATES)
7.10 KEDRION S.P.A. (ITALY)
7.11 OCTAPHARMA AG (SWITZERLAND)
7.12 PFIZER INC. (UNITED STATES)
7.13 SANQUIN BLOOD SUPPLY FOUNDATION (NETHERLANDS)
7.14 SHIRE (NOW PART OF TAKEDA PHARMACEUTICAL COMPANY) (JAPAN)
7.15 SICHUAN KELUN PHARMACEUTICAL CO. LTD. (CHINA)
7.16 TERUMO CORPORATION (JAPAN)
7.17 ZHONGYUAN UNION CELL & GENE ENGINEERING CORP. LTD. (CHINA)
7.18 OTHER ACTIVE PLAYERS
Chapter 8: Global Plasma Expander Market By Region
8.1 Overview
8.2. North America Plasma Expander Market
8.2.1 Key Market Trends, Growth Factors and Opportunities
8.2.2 Top Key Companies
8.2.3 Historic and Forecasted Market Size by Segments
8.2.4 Historic and Forecasted Market Size By Type
8.2.4.1 Pure PRP Leucocyte-rich PRP Pure Platelet-rich Fibrin (PRF) Leukocyte-rich Fibrin (L-PRF)
8.2.5 Historic and Forecasted Market Size By Application
8.2.5.1 Infectious Diseases Dental Nerve Injury Cardiac Muscle Injury Other
8.2.6 Historic and Forecasted Market Size By End User
8.2.6.1 Hospitals and Clinics Research Institutes Others
8.2.7 Historic and Forecast Market Size by Country
8.2.7.1 US
8.2.7.2 Canada
8.2.7.3 Mexico
8.3. Eastern Europe Plasma Expander Market
8.3.1 Key Market Trends, Growth Factors and Opportunities
8.3.2 Top Key Companies
8.3.3 Historic and Forecasted Market Size by Segments
8.3.4 Historic and Forecasted Market Size By Type
8.3.4.1 Pure PRP Leucocyte-rich PRP Pure Platelet-rich Fibrin (PRF) Leukocyte-rich Fibrin (L-PRF)
8.3.5 Historic and Forecasted Market Size By Application
8.3.5.1 Infectious Diseases Dental Nerve Injury Cardiac Muscle Injury Other
8.3.6 Historic and Forecasted Market Size By End User
8.3.6.1 Hospitals and Clinics Research Institutes Others
8.3.7 Historic and Forecast Market Size by Country
8.3.7.1 Russia
8.3.7.2 Bulgaria
8.3.7.3 The Czech Republic
8.3.7.4 Hungary
8.3.7.5 Poland
8.3.7.6 Romania
8.3.7.7 Rest of Eastern Europe
8.4. Western Europe Plasma Expander Market
8.4.1 Key Market Trends, Growth Factors and Opportunities
8.4.2 Top Key Companies
8.4.3 Historic and Forecasted Market Size by Segments
8.4.4 Historic and Forecasted Market Size By Type
8.4.4.1 Pure PRP Leucocyte-rich PRP Pure Platelet-rich Fibrin (PRF) Leukocyte-rich Fibrin (L-PRF)
8.4.5 Historic and Forecasted Market Size By Application
8.4.5.1 Infectious Diseases Dental Nerve Injury Cardiac Muscle Injury Other
8.4.6 Historic and Forecasted Market Size By End User
8.4.6.1 Hospitals and Clinics Research Institutes Others
8.4.7 Historic and Forecast Market Size by Country
8.4.7.1 Germany
8.4.7.2 UK
8.4.7.3 France
8.4.7.4 The Netherlands
8.4.7.5 Italy
8.4.7.6 Spain
8.4.7.7 Rest of Western Europe
8.5. Asia Pacific Plasma Expander Market
8.5.1 Key Market Trends, Growth Factors and Opportunities
8.5.2 Top Key Companies
8.5.3 Historic and Forecasted Market Size by Segments
8.5.4 Historic and Forecasted Market Size By Type
8.5.4.1 Pure PRP Leucocyte-rich PRP Pure Platelet-rich Fibrin (PRF) Leukocyte-rich Fibrin (L-PRF)
8.5.5 Historic and Forecasted Market Size By Application
8.5.5.1 Infectious Diseases Dental Nerve Injury Cardiac Muscle Injury Other
8.5.6 Historic and Forecasted Market Size By End User
8.5.6.1 Hospitals and Clinics Research Institutes Others
8.5.7 Historic and Forecast Market Size by Country
8.5.7.1 China
8.5.7.2 India
8.5.7.3 Japan
8.5.7.4 South Korea
8.5.7.5 Malaysia
8.5.7.6 Thailand
8.5.7.7 Vietnam
8.5.7.8 The Philippines
8.5.7.9 Australia
8.5.7.10 New Zealand
8.5.7.11 Rest of APAC
8.6. Middle East & Africa Plasma Expander Market
8.6.1 Key Market Trends, Growth Factors and Opportunities
8.6.2 Top Key Companies
8.6.3 Historic and Forecasted Market Size by Segments
8.6.4 Historic and Forecasted Market Size By Type
8.6.4.1 Pure PRP Leucocyte-rich PRP Pure Platelet-rich Fibrin (PRF) Leukocyte-rich Fibrin (L-PRF)
8.6.5 Historic and Forecasted Market Size By Application
8.6.5.1 Infectious Diseases Dental Nerve Injury Cardiac Muscle Injury Other
8.6.6 Historic and Forecasted Market Size By End User
8.6.6.1 Hospitals and Clinics Research Institutes Others
8.6.7 Historic and Forecast Market Size by Country
8.6.7.1 Turkiye
8.6.7.2 Bahrain
8.6.7.3 Kuwait
8.6.7.4 Saudi Arabia
8.6.7.5 Qatar
8.6.7.6 UAE
8.6.7.7 Israel
8.6.7.8 South Africa
8.7. South America Plasma Expander Market
8.7.1 Key Market Trends, Growth Factors and Opportunities
8.7.2 Top Key Companies
8.7.3 Historic and Forecasted Market Size by Segments
8.7.4 Historic and Forecasted Market Size By Type
8.7.4.1 Pure PRP Leucocyte-rich PRP Pure Platelet-rich Fibrin (PRF) Leukocyte-rich Fibrin (L-PRF)
8.7.5 Historic and Forecasted Market Size By Application
8.7.5.1 Infectious Diseases Dental Nerve Injury Cardiac Muscle Injury Other
8.7.6 Historic and Forecasted Market Size By End User
8.7.6.1 Hospitals and Clinics Research Institutes Others
8.7.7 Historic and Forecast Market Size by Country
8.7.7.1 Brazil
8.7.7.2 Argentina
8.7.7.3 Rest of SA
Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies
Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research
|
Global Plasma Expander Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 6.97 Billion |
|
Forecast Period 2024-32 CAGR: |
12.7 % |
Market Size in 2032: |
USD 20.44 Billion |
|
Segments Covered: |
By Type |
|
|
|
By Application |
|
||
|
By End User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
